Hidroksiklorokiini

Hidroksiklorokiini, also known as hydroxychloroquine, is a medication used to treat malaria, rheumatoid arthritis, and lupus. It belongs to a class of drugs called antimalarials and anti-inflammatory agents. The medication works by interfering with the growth of the malaria parasite and by reducing inflammation in the body.

Hidroksiklorokiini is available in tablet form and is typically taken orally, usually once or twice daily. The dosage and duration of treatment vary depending on the condition being treated and the individual patient's needs. Common side effects of hidroksiklorokiini include nausea, vomiting, diarrhea, and stomach cramps.

Some studies have suggested that hidroksiklorokiini may also have antiviral properties, which could potentially be used to treat COVID-19. However, more research is needed to confirm these findings and to determine the safety and efficacy of the medication for this use. The US FDA has issued an emergency use authorization for hidroksiklorokiini to be used in hospitalized patients with COVID-19, but the medication has not been approved for widespread use in this population.

Hidroksiklorokiini has been used for many years to treat malaria and other conditions, and it is generally considered safe for short-term use. However, long-term use can cause serious side effects, such as retinal damage and heart rhythm problems. Patients taking hidroksiklorokiini should have regular eye exams and blood tests to monitor for these and other potential side effects.